HTA Database - Search Results

Sort by Relevance

Search Results [15895 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2011	NIHR Health Technology Assessment programme	Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review
2011	NIHR Health Technology Assessment programme	Hemiarthroplasty and total hip arthroplasty for treating primary intracapsular fracture of the hip: a systematic review and cost-effectiveness analysis
2011	NIHR Health Technology Assessment programme	A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2011	NIHR Health Technology Assessment programme	Liraglutide for the treatment of type 2 diabetes
2011	NIHR Health Technology Assessment programme	Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura
2011	NIHR Health Technology Assessment programme	Golimumab for the treatment of ankylosing spondylitis
2011	NIHR Health Technology Assessment programme	Retigabine for the adjunctive treatment of adults with partial onset seizures in epilepsy with and without secondary generalisation
2011	NIHR Health Technology Assessment programme	Bivalirudin for the treatment of ST-segment elevation myocardial infarction
2011	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	Ticagrelor for the treatment of acute coronary syndromes
2011	NIHR Health Technology Assessment programme	Eribulin for the treatment of locally advanced or metastatic breast cancer
2011	NIHR Health Technology Assessment programme	Fingolimod for the treatment of relapsing remitting multiple sclerosis
2011	NIHR Health Technology Assessment programme	Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
2011	NIHR Health Technology Assessment programme	Denosumab for osteoporotic fractures in post menopausal women primary and secondary prevention
2011	NIHR Health Technology Assessment programme	Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing therapy
2011	NIHR Health Technology Assessment programme	Mannitol dry powder for inhalation for the treatment of cystic fibrosis
2011	NIHR Health Technology Assessment programme	Belimumab for the treatment of active autoantibody-positive systemic lupus erythematosus
2011	NIHR Health Technology Assessment programme	Fulvestrant for the treatment of locally advanced or metastatic breast cancer
2011	NIHR Health Technology Assessment programme	Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK
2011	NIHR Health Technology Assessment programme	Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11
2011	NIHR Health Technology Assessment programme	Ranibizumab for the treatment of macular oedema caused by retinal vein occlusion (RVO): a single technology appraisal
2011	NIHR Health Technology Assessment programme	Trabectedin for the treatment of relapsed ovarian cancer
2011	NIHR Health Technology Assessment programme	Roflumilast for the management of severe chronic obstructive pulmonary disease
2011	NIHR Health Technology Assessment programme	Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction
2011	NIHR Health Technology Assessment programme	Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer
2011	NIHR Health Technology Assessment programme	A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease
2011	NIHR Health Technology Assessment programme	Prucalopride for the treatment of chronic constipation in women in whom laxatives fail to provide adequate relief
2011	NIHR Health Technology Assessment programme	Golimumab for the treatment of psoriatic arthritis
2011	Belgian Health Care Knowledge Centre (KCE)	Transcatheter aortic valve implantation (TAVI): an updated health technology assessment
2011	HAYES, Inc.	Acticoat (Smith&Nephew Inc.) for Burn Wounds
2011	HAYES, Inc.	Antibacterial suture for prevention of infection
2011	HAYES, Inc.	Bipolar plasmakinetic electrovaporization for benign prostatic hyperplasia (BPH)
2011	HAYES, Inc.	Endoscopic cyclophotocoagulation for glaucoma
2011	HAYES, Inc.	Intermittent pneumatic compression therapy for mastectomy-related lymphedema
2011	HAYES, Inc.	Intrauterine balloon tamponade for the management of postpartum hemorrhage
2011	HAYES, Inc.	Intravenous ketamine for chronic nonmalignant pain
2011	HAYES, Inc.	Near-infrared spectroscopy (INVOS cerebral/somatic oximeter) (Covidien) for adult cerebral indications
2011	HAYES, Inc.	Neutralizing Antibody (NAb) testing using the myxovirus protein A (MxA) assay to assess interferon beta treatment of multiple sclerosis
2011	HAYES, Inc.	On-X prosthetic heart valve (On-X Life Technologies Inc.) for cardiac valve replacement
2011	NIHR Health Technology Assessment programme	Ranibizumab for the treatment of diabetic macular oedema
2011	HAYES, Inc.	Promacta (eltrombopag) tablets (GlaxoSmithKline) for chronic idiopathic thrombocytopenic purpura (ITP)
2011	HAYES, Inc.	Rituxan (Rituximab) (Genentech Inc. and Biogen Idec Inc.) for Chronic Lymphocytic Leukemia(CLL)
2011	HAYES, Inc.	SprayShield adhesion barrier system (Covidien Inc.) for prevention of postoperative adhesions
2011	HAYES, Inc.	Topaz MicroDebrider (ArthroCare Corp.) for treatment of tendon disorders of the upper extremities
2011	HAYES, Inc.	Previstage GCC colorectal cancer staging test
2011	HAYES, Inc.	Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS; Familial Hibernian Fever)
2011	HAYES, Inc.	Brachytherapy for breast cancer
2011	HAYES, Inc.	Cognitive-behavioral therapy for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
2011	HAYES, Inc.	Full-field digital mammography for breast cancer screening
2011	HAYES, Inc.	Lipoprotein-associated phospholipase testing for stroke assessment in adults
2011	HAYES, Inc.	Minimally invasive total hip arthroplasty
2011	HAYES, Inc.	Nicotine replacement therapy for smoking cessation: nicotine gum and nicotine lozenge
2011	HAYES, Inc.	Nicotine replacement therapy for smoking cessation: nicotine nasal spray and nicotine inhaler
2011	HAYES, Inc.	Nicotine replacement therapy for smoking cessation: nicotine patch
2011	HAYES, Inc.	NovoSeven coagulation factor VIIa (recombinant) for prevention and control of bleeding in patients without hemophilia
2011	HAYES, Inc.	Osteopathic Manipulative Treatment (OMT) for back pain
2011	HAYES, Inc.	Photographic surveillance for early detection of malignant melanoma
2011	HAYES, Inc.	Platelet-rich plasma for ligament and tendon injuries
2011	HAYES, Inc.	Positron Emission Tomography (PET) for alzheimer's disease
2011	HAYES, Inc.	Radiofrequency ablation of the pulmonary veins for the treatment of atrial fibrillation
2011	HAYES, Inc.	Transvaginal ultrasound for measurement of cervical length to predict preterm birth
2011	The Swedish Council on Health Technology Assessment (SBU)	[Peripherally Inserted Central Venous Catheter (PICC)]
2011	The Swedish Council on Health Technology Assessment (SBU)	[Vacuum assisted wound closure therapy]
2011	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Bioimpedance vector analysis in the assessment of nutritional status and body fluid volume in patients with chronic renal failure]
2011	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[ReWalk(tm): motorized orthosis in wheelchair users paraplegic people]
2011	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Hypothermia therapy for treatment of neonatal hypoxic-ischemic encephalopathy]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pre-operative skin preparation solutions: a review of the evidence on safety
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	MAKO's RESTORIS implants and MAKOplasty procedure for early to mid-stage osteoarthritic knee disease: a review of the clinical and cost-effectiveness and safety
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Blood pressure monitoring chairs to identify hypertension: a review of the clinical effectiveness and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Interferon-gamma release assays testing versus tuberculosis skin testing for tuberculosis: a review of the clinical effectiveness and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Point of care cholesterol testing for coronary heart disease: a review of the clinical effectiveness and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Disposable gloves for use in healthcare settings: a review of the clinical effectiveness, safety, cost-effectiveness, and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Mycophenolate mofetil tablets for uveitis: a review of the comparative clinical and cost-effectiveness
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Safety of leflunomide and methotrexate as combination therapy for rheumatoid arthritis: a review of the clinical evidence
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening and assessment tools for patients with chronic disease in therapeutic exercise program: a review of the clinical evidence and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Parenteral versus oral methotrexate for the treatment of rheumatoid arthritis: a review of the clinical evidence
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting spinal anesthetics for outpatient procedures: a review of the clinical evidence and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Central monitors for acutely-ill cardiac patients in a small, rural hospital setting: a review of clinical and cost-effectiveness
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Quality assessment of the Canadian attention deficit hyperactivity disorder resource alliance ADHD practice guidelines for children, adolescents and adults with ADHD
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Benzodiazepines in older adults: a review of clinical effectiveness, cost-effectiveness, and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Safety of air vents in psychiatric units in a hospital setting: a review of the clinical evidence and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	MALDI-TOF mass spectrometry for bacterial species identification: a review of diagnostic accuracy and clinical and cost-effectiveness
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ventilation/perfusion scintigraphy (using Technegas) versus computed tomography pulmonary angiography for the diagnosis of pulmonary embolism in hospitalized patients: a review of the clinical and cost-effectiveness
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of urea breath test for helicobacter pylori detection]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Nucleoplasty for patients with discogenic back pain]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Therapeutic hypothermia in patients with stroke or brain trauma]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Vagus nerve stimulation for refractory epilepsy]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Sacral nerve stimulation for the treatment of voiding dysfunction]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Therapeutic hypothermia in patients who underwent cardiac arrest resuscitation]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Botulinum toxin use in adults and children with urinary tract function disorders]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pipeline embolization device]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of video EEG for the assessment of patients with refractory epilepsy]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Endoscopic mucosectomy for the treatment of sessile polyps ]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Effectiveness of eculizumab in the treatment of paroxysmal nocturnal hemoglobinuria]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Toric intraocular lenses]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Electrical stimulation devices to treat delayed unions and pseudarthrosis]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of prometheus in severe liver failure]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Arrhythmia ablation by EnSite NavX electroanatomical mapping]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Drug-eluting balloon for the treatment of coronary stenosis]